Cheon Jae Hee, Kim Jae Hak, Kim Bo Young, Kim Seung Won, Hong Sung Yi, Eun Chang Soo, Hong Seong Soo, Byeon Jeong-Sik, Kim Tae Il, Han Dong Soo, Yang Suk-Kyun, Lee Kyoung Ryul, Kim Won Ho
Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Hepatogastroenterology. 2009 Mar-Apr;56(90):421-3.
BACKGROUND/AIMS: Adverse reactions to thiopurines may be predisposed by thiopurine methyltransferase (TPMT) or inosine triphosphate pyrophosphatase (ITPA) gene mutations.
We examined the frequencies of TPMT and ITPA gene polymorphisms in 812 Korean patients with inflammatory bowel diseases using denaturing high performance liquid chromatography and direct sequencing.
The allele frequencies of TPMT2, TPMT3A, TPMT3B, and TPMT3C were 0, 0, 0, and 0.010 (17/1624), respectively. For the ITPA polymorphism, 173 subjects were heterozygous and 5 were homozygous for the 94C>A missense mutation (allele frequency of A, 0.113). Moreover, the 87T>C, IVS2+21A>C, and IVS2+53C>T polymorphisms were found in one patient each (1/1624), respectively. Of these, 87T>C and IVS2+53C>T were novel single nucleotide polymorphisms of the ITPA gene whose clinical significance should be further evaluated.
Our data describe TPMT and ITPA gene mutation patterns among Koreans and provide a basis for screening studies to identify patients at high risk for myelotoxicity from thiopurine drugs.
背景/目的:硫嘌呤甲基转移酶(TPMT)或肌苷三磷酸焦磷酸酶(ITPA)基因突变可能会引发对硫嘌呤类药物的不良反应。
我们使用变性高效液相色谱法和直接测序法,检测了812例韩国炎症性肠病患者中TPMT和ITPA基因多态性的频率。
TPMT2、TPMT3A、TPMT3B和TPMT3C的等位基因频率分别为0、0、0和0.010(17/1624)。对于ITPA多态性,173名受试者为94C>A错义突变的杂合子,5名受试者为该突变的纯合子(A的等位基因频率为0.113)。此外,87T>C、IVS2+21A>C和IVS2+53C>T多态性分别在1例患者中发现(1/1624)。其中,87T>C和IVS2+53C>T是ITPA基因的新型单核苷酸多态性,其临床意义有待进一步评估。
我们的数据描述了韩国人群中TPMT和ITPA基因突变模式,并为筛查研究提供了依据,以识别硫嘌呤类药物骨髓毒性高危患者。